Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 4
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

Mycoplasma bovis is a highly contagious pathogen that causes clinical or subclinical mastitis. The present study was aimed for the isolation, molecular characterization and antibiogram determination of M. bovis from raw milk samples. Milk samples were collected randomly from lactating cows and buffaloes from different tehsils of district Faisalabad, Pakistan. Samples were inoculated on modified Hayflick medium and biochemical tests were performed for further confirmation of isolated M. bovis. Out of total 400 milk samples, 184 (46%) samples were found positive for culture method. The 16S-rRNA gene polymerase chain reaction was performed for molecular characterization of isolated M. bovis strains. Out of total 400 milk samples, 240 (60%) positive for M. bovis through PCR method were examined. The 16S-rRNA gene PCR positive isolated M. bovis strains were sequenced and results were compared using Maximum-likelihood method and sequenced strains of M. bovis were aligned and analyzed by Clustal W software. Antibiogram of isolated M. bovis strains was analyzed by disc diffusion assay against eight commonly used antibiotics. Tylosin (30μg) and Tilmicosin (15ug) showed inhibition zones of 32.34 ± 1.10 mm and 17.12 ± 0.93 mm respectively against isolated M. bovis which were found sensitive. Isolated M. bovis was found resistant to other commonly used antibiotics. Statistical analysis revealed that p-value was < 0.05 and the odds ratio was >1.0 at 95% CI. This study complemented the lack of epidemiological knowledge of molecular characterization, comparative effectiveness and resistance trends of isolated M. bovis strains against commonly used antibiotics.
Go to article

Bibliography

  1. Adorno BM, Salina A, Joaquim S, Guimarães FF, Lopes BC, Menozzi B, Langoni H (2021) Presence of Mollicutes and Mycoplasma bovis in nasal swabs from calves and in milk from cows with clinical mastitis. Vet Zootec 28: 001-009.
  2. Ahmad Z, Babar S, Abbas F, Awan MA, Abubakar M, Attique MA, Hassan Y, Rashid N, Ali M (2011) Identification and molecular characterization of Mycoplasma species from bovine lungs samples collected from slaughter house, Quetta, Balochistan, Pakistan. Pak J Life Soc Sci 9: 91-97.
  3. Ahmad Z, Babar S, Abbas F, Awan MA, Shafee M, Tariq MM, Mengal MA, Rashid N, Amin S, Taj K, Ali M (2014) Prevalence of Mycoplasma bovis in respiratory tract of cattle slaughtered in Balochistan, Pakistan. Pak Vet J 34: 46-49.
  4. Alhussen MA, Kirpichenko VV, Yatsentyuk SP, Nesterov AA, Byadovskaya OP, Zhbanovat TV, Sprygin AV (2021) Mycoplasma bovis, M. bovigenitalium and M. dispar as Bovine Pathogens: Brief characteristics of the pathogens (review). Agric Biol 56: 245-260.
  5. Kumar A, Verma AK, Gangwar NK, Rahal A (2012) Isolation, characterization and antibiogram of Mycoplasma bovis in sheep pneumonia. Asian J Anim Vet Adv 7: 149-157.
  6. Behera S, Rana R, Gupta PK, Kumar D, Sonal, Rekha V, Arun TR, Jena D (2018) Development of real- time PCR assay for the detection of Mycoplasma bovis. Trop Anim Health Prod 50: 875-882.
  7. Bokma J, Vereecke N, De Bleecker K, Callens J, Ribbens S, Nauwynck H, Haesebrouck F, Theuns S, Boyen F, Pardon B (2020) Phylogenomic analysis of Mycoplasma bovis from Belgian veal, dairy and beef herds. Vet Res 51: 121.
  8. Bokma J, Vereecke N, Nauwynck H, Haesebrouck F, Theuns S, Pardon B, Boyen F (2021) Genome-wide association study reveals genetic markers for antimicrobial resistance in Mycoplasma bovis. Microbiol Spectr 9: e0026221.
  9. Buller H, Blokhuis H, Jensen P, Keeling L (2018) Towards farm animal welfare and sustainability. Animals 2018, 8: 81.
  10. Caria M, Boselli C, Murgia L, Rosati R, Pazzona A (2013) Influence of low vacuum levels on milking characteristics of sheep, goat and buffalo. J Agr Eng 44: 217- 220.
  11. Cheng WN, Han SG (2020) Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments – A review. Asian-Australas J Anim Sci . 33: 1699-1713.
  12. Deeney A S, Collins R, Ridley AM (2021) Identification of Mycoplasma species and related organisms from ruminants in England and Wales during 2005-2019. BMC Vet Res 17: 325.
  13. Farid MA, Abo-Shosha AA, Belal ES, Hassan MM (2018) Genotyping of pathogenic Mycoplasma bovis isolated from cattle in Kafr El-Sheikh Province, Egypt. J Pure Appl Microbiol. 12: 2103-2109.
  14. Ghafar A, Mcgill D, Stevenson MA, Badar M, Kumbher A, Warriach MH, Gasser RB, Jabbar A (2020) A participatory investigation of bovine health and production issues in Pakistan. Front Vet Sci 7: 248.
  15. Hata E, Harada T, Itoh M (2019) Relationship between antimicrobial susceptibility and multilocus sequence type of Mycoplasma bovis isolates and development of a method for rapid detection of point mutations involved in decreased susceptibility to macrolides, lincosamides, tetracyclines, and spectinomycin. Appl Environ Microbiol 85: e0057519.
  16. Hudzicki J (2009) Kirby-Bauer disk diffusion susceptibility test protocol. Am J Mol Biol 8: 2009.
  17. Ilyas F, Gillani DQ, Yasin M, Iqbal MA, Javed I, Ahmad S, Nabi I (2022) Impact of Livestock and Fisheries on Economic Growth: An Empirical Analysis from Pakistan. Sarhad J Agric 38: 160-169.
  18. Imandar M, Pourbakhsh SA, Jamshidian M, Salehi TZ (2018) Isolation, identification and molecular characterization of Mycoplasma bovis in mastitic dairy cattle by PCR and culture methods. J Hell Vet Med Soc 69: 815-822.
  19. Imran M, Rehman I, Sulehria AQ, Butt YM, Khan AM, Ziauddin A (2021) Profile of Antimicrobial Susceptibility from Cattles’s Milk Isolates Suffering from Mastitis in District Lahore. J Biores Manag 8: 6-14.
  20. Khan ZU (2022) Laws, Issues, Challenges, Analysis of Livestock Sector and International Best Practices. J Dev Soc Sci 3: 271-283.
  21. Klein U, de Jong A, Moyaert H, El Garch F, Leon R, Richard-Mazet A, Rose M, Maes D, Pridmore A, Thomson JR, Ayling RD (2017) Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae and Mycoplasma bovis isolated in Europe. Vet Microbiol 204: 188-193.
  22. Konigsson MH, Bolske G, Johansson KE (2002) Intraspecific variation in the 16S- rRNA gene sequences of Mycoplasma agalactiae and Mycoplasma bovis strains. Vet Microbiol 85: 209-220.
  23. Mahmood F, Khan A, Hussain R, Khan IA, Abbas RZ, Ali HM, Younus M (2017) Patho-bacteriological investigation of an outbreak of Mycoplasma bovis infection in calves-Emerging stealth assault. Microb Pathog 107: 404-408.
  24. Maunsell FP, Donovan GA, (2009) Mycoplasma bovis infections in young calves. Vet Clin North Am Food Anim Pract 25: 139-177.
  25. Maunsell FP, Woolums AR, Francoz D, Rosenbusch RF, Step DL, Wilson DJ, Janzen ED (2011) Mycoplasma bovis infections in cattle. J Vet Inter Med 25: 772-783.
  26. Mojsoska B, Ghoul M, Perron GG, Jenssen H, Alatraktchi FA (2021) Changes in toxin production of environmental Pseudomonas aeruginosa isolates exposed to sub- inhibitory concentrations of three common antibiotics. PloS One 16: e0248014.
  27. Nicholas RA, Fox LK, Lysnyansky I (2016) Mycoplasma mastitis in cattle: To cull or not to cull. Vet J 216: 142-147.
  28. Niu J, Wang D, Yan M, Chang Z, Xu Y, Sizhu S, Li Z, Hu S, Bi D (2021) Isolation, identification and biological characteristics of Mycoplasma bovis in yaks. Microb Pathog 150: 104691.
  29. Pal A, Chakravarty AK (2020) Disease resistance for different livestock species. Genet Breed Dis Resist Livest 2020: 271-296.
  30. Passchyn P, Piepers S, De Meulemeester L, Boyen F, Haesebrouck F, De Vliegher S (2012) Between-herd prevalence of Mycoplasma bovis in bulk milk in Flanders, Belgium Res Vet Sci 92: 219-220.
  31. Perez-Casal J, Prysliak T, Maina T, Suleman M, Jimbo S (2017) Status of the development of a vaccine against Mycoplasma bovis. Vaccine 35: 2902-2907.
  32. Romero J, Benavides E, Meza C (2018) Assessing financial impacts of subclinical mastitis on Colombian dairy farms. Front Vet Sci 5: 273
  33. Rossetti BC, Frey J, Pilo P (2010) Direct detection of Mycoplasma bovis in milk and tissue samples by real-time PCR. Molar Cell Pro. 24: 321-323.
  34. Salina A, Timenetsky J, Barbosa MS, Azevedo CM, Langoni H (2020) Microbiological and molecular detection of Mycoplasma bovis in milk samples from bovine clinical mastitis. Pesqui Vet Bras 40: 82-87.
  35. Shao Y, Wang Y, Yuan Y, Xie Y (2021) A systematic review on antibiotics misuse in livestock and aquaculture and regulation implications in China. Sci Total Environ 798: 149205.
  36. Abadi AT, Rizvanov AA, Haertlé T, Blatt NL (2019) World Health Organization report: current crisis of antibiotic resistance. BioNanoScience 9: 778-788.
  37. Gogoi-Tiwari J, Tiwari HK, Wawegama NK, Premachandra C, Robertson ID, Fisher AD, Waichigio FK, Irons P, Aleri JW (2022) Prevalence of Mycoplasma bovis Infection in Calves and Dairy Cows in Western Australia. Vet Sci 9: 351-358.
  38. Vereecke N, Bokma J, Haesebrouck F, Nauwynck H, Boyen F, Pardon B, Theuns S (2020) High quality genome assemblies of Mycoplasma bovis using a taxon- specific Bonito basecaller for MinION and Flongle long-read nanopore sequencing. BMC Bioinform 21: 517.
  39. Verraes C, Claeys W, Cardoen S, Daube G, De Zutter L, Imberechts H, Dierick K, Herman L (2014) A review of the microbiological hazards of raw milk from animal species other than cows. Inter Dairy J 39: 121-130.
  40. Wisselink HJ, Smid B, Plater J, Ridley A, Andersson AM, Aspan A, Pohjanvirta T, Vahanikkila N, Larsen H, Hogberg J, Colin A, Tardy F (2019) A European interlaboratory trial to evaluate the performance of different PCR methods for Mycoplasma bovis diagnosis. BMC Vet Res 15: 86.
Go to article

Authors and Affiliations

A. Jabbar
1
M. Ashraf
1
S.U. Rahman
1
M.S. Sajid
2

  1. Institute of Microbiology, University of Agriculture, Jail Road, Faisalabad, Punjab 38000, Pakistan
  2. Department of parasitology, University of Agriculture, Jail Road, Faisalabad, Punjab 38000, Pakistan
Download PDF Download RIS Download Bibtex

Abstract

Viral diseases have caused devastating effect on poultry industry leading to significant losses in economy of world. In the presented study, the ability of Newcastle disease virus (NDV), infectious bursal disease virus (IBDV) and avian influenza virus (AIV) to grow in two cell lines was evaluated. Both chicken embryo fibroblast (CEF) and DF-1 cells were used and cytopathic effects (CPE) produced by these viruses were observed. The titer of virus in terms of TCID50 was determined after 24h up to four days for each virus. The same type of CPE was observed for all viruses used in the study in both DF-1 and CEF cells. IBDV showed CPE causing rounding of cells while NDV caused formation of multicellular large nuclei, cell fusion and rounding of cells. Giant cells with inclusions and aggregation of cells with intact monolayer was observed for AIV. In growth kinetic study, higher titer of IBDV and NDV was observed in CEF cells than DF-1 cells while for AIV, DF-1 cells showed higher titer than CEF cells. These results would be useful for furthers comparative studies on growth of different cell lines of various viruses to find a suitability for vaccine production.
Go to article

Authors and Affiliations

S. Anam
1
S.U. Rahman
1
Shazma Ali
M. Saeed
2
S.M. Goyal
3

  1. Institute of Microbiology, Faculty of Veterinary Science, University of Agriculture Faisalabad, Pakistan
  2. National Institute of Food Science and Technology, University of Agriculture Faisalabad, Pakistan
  3. College of Veterinary Population Medicine, 1333 Gortner Avenue, University of Minnesota, USA
Download PDF Download RIS Download Bibtex

Abstract

Babesiosis is a parasitic disease caused by intraerythrocytic parasites of the genus Babesia, which infect both wild and domestic animals. Merozoite surface antigens (MSAs) have been identified as efficient immunogens in Babesia-infected animals. MSAs play a key role in the invasion process and have been proposed as potential targets for vaccine development. Epitope-based vaccines offer several advantages over whole protein vaccines as the immunogenic proteins are small and can induce both Th1 and Th2 immune responses, which are desirable for protection. However, the MSA, particularly gp45, is polymorphic in Babesia bigemina, posing a challenge to vaccine development. The purpose of this study was to develop a recombinant gpME (gp45-multi-epitope) for a vaccine against Babesia bigemina. B-cell, T-cell, and HLA epitope predictions were used to synthesize the gpME sequence from the consensus sequence of gp45. The gpME sequence was synthesized and cloned in the pET28α vector through the commercial biotechnology company to get pET28-gpME. The plasmid cloned with the gpME sequence comprising 1068 bp was expressed in a bacterial expression system. A band of 39 kDa of rec-gpME was obtained via SDS-PAGE and Western blotting. Rec-gpME @200ng was injected in calves 3 times at 2 weeks interval. The humoral response was evaluated through the indirect ELISA method. The ELISA with rec-gp45 protein showed a significant value of optical density. The recombinant protein containing multiple epitopes from the MSA gp45 may represent a promising candidate for a vaccine against Babesia bigemina.
Go to article

Bibliography

  1. Adu-Bobie J, Capecchi B, Serruto D, Rappuoli R, Pizza M (2003) Two years into reverse vaccinology. Vaccine 21: 605-610.
  2. Bock RE, De Vos AJ (2001) Immunity following use of Australian tick fever vaccine: a review of the evidence. Aust Vet J 79: 832-839.
  3. Callow LL, Dalgliesh RJ, De Vos AJ (1997) Development of effective living vaccines against Bovine Babesiosis – the longest field trial? Int J Parasitol 27: 747-767.
  4. Carcy B, Précigout E, Schetters T, Gorenflot A (2006) Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity. Vet Parasitol 138: 33-49.
  5. Caro-Gomez E, Gazi M, Goez Y, Valbuena G (2014) Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach. Vaccine 32: 4968-4976.
  6. Çiloğlu A, Abdullah IN, Yildirim A, Önder Z, Düzlü Ö (2018) Molecular characterization and expression of the apical membrane antigen-1 from in vivo and in vitro isolates of Babesia bigemina Kayseri/Turkey strain. Ankara Univ Vet Fak Derg 65: 239-246.
  7. de Castro JJ (1997) Sustainable tick and tickborne disease control in livestock improvement in developing countries. Vet Parasitol 71: 77-97.
  8. Debierre-Grockiego F, Schwarz RT (2010) Immunological reactions in response to apicomplexan glycosylphosphatidylinositols. Glycobiology 20: 801-811.
  9. Debierre-Grockiego F, Smith TK, Delbecq S, Ducournau C, Lantier L, Schmidt J, Brès V, Dimier-Poisson I, Schwarz RT, Cornillot E (2019) Babesia divergens glycosylphosphatidylinositols modulate blood coagulation and induce Th2-biased cytokine profiles in antigen presenting cells. Biochimie 167: 135-144.
  10. Delbecq S, Hadj-Kaddour K, Randazzo S, Kleuskens J, Schetters T, Gorenflot A, Précigout E (2006) Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplexan Babesia divergens. Vaccine 24: 613-621.
  11. Djokic V, Akoolo L, Parveen N (2018) Babesia microti infection changes host spleen architecture and is cleared by a Th1 immune response. Front Microbiol 9:85
  12. Durrani A, Kamal N (2008) Identification of ticks and detection of blood protozoa in Friesian cattle by polymerase chain reaction test and estimation of blood parameters in district Kasur, Pakistan. Trop Anim Health Prod 40: 441-447.
  13. Echaide IE, De Echaide ST, Guglielmone AD (1993) Live and soluble antigens for cattle protection to Babesia bigemina. Vet Parasitol 51: 35-40.
  14. Esmaeilnejad B, Tavassoli M, Asri-Rezaei S, Dalir-Naghadeh B, Mardani K, Golabi M, Arjmand J, Kazemnia A, Jalilzadeh G (2015) Determination of prevalence and risk factors of infection with Babesia ovis in small ruminants from West Azerbaijan Province, Iran by polymerase chain reaction. J Arthropod Borne Dis 9: 246-252.
  15. Ezediuno LO, Onile OS, Oladipo EK, Majolagbe ON, Jimah EM, Senbadejo TY (2021) Designing multi-epitope subunit vaccine for ocular trachoma infection using Chlamydia trachomatis polymorphic membrane proteins G. Inform Med Unlocked 26: 100764.
  16. Fisher TG, McElwain TF, Palmer GH (2001) Molecular basis for variable expression of merozoite surface antigen gp45 among American isolates of Babesia bigemina. Infect Immun 69: 3782-3790.
  17. Gaafar B, Ali SA, Abd-Elrahman KA, Almofti YA (2019) Immunoinformatics approach for multiepitope vaccine prediction from H, M, F, and N proteins of Peste des Petits ruminants virus. J Immunol Res 2019. 6124030
  18. Gomara MJ, Haro I (2007) Synthetic peptides for the immunodiagnosis of human diseases. Curr Med Chem 14: 531-546.
  19. Hajissa K, Zakaria R, Suppian R, Mohamed Z (2019) Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: A mini-review. J Adv Vet Anim Res 6: 174-182.
  20. Jabbar A, Abbas T, Sandhu Z, Saddiqi HA, Qamar MF, Gasser RB (2015) Tick-borne diseases of bovines in Pakistan: major scope for future research and improved control. Parasit Vectors 8:.283
  21. Jorgensen WK, De Vos AJ, Dalgliesh RJ (1989) Comparison of immunogenicity and virulence between Babesia bigemina parasites from continuous culture and from a splenectomised calf. Aust Vet J 66: 371-372.
  22. Kalita J, Padhi AK, Tripathi T (2020a) Designing a vaccine for fascioliasis using immunogenic 24 kDa mu-class glutathione s-transferase. Infect Genet Evol 83: 104352.
  23. Kalita P, Padhi AK, Zhang KY, Tripathi T (2020b) Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. Microb Pathog 145: 104236.
  24. Kar PP, Srivastava A (2018) Immuno-informatics analysis to identify novel vaccine candidates and design of a multi-epitope based vaccine candidate against Theileria parasites. Front Immunol 9: 2213.
  25. Karim S, Budachetri K, Mukherjee N, Williams J, Kausar A, Hassan MJ, Adamson S, Dowd SE, Apanskevich D, Arijo A, Sindhu ZU (2017) A study of ticks and tick-borne livestock pathogens in Pakistan. PLOS Negl Trop Dis 11: e0005681.
  26. Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, Thierer T ( 2012) Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28: 1647-1649.
  27. Khatoon N, Ojha R, Mishra A, Prajapati VK (2018) Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism. Vaccine 36: 6290-6300.
  28. Klafke G, Webster A, Agnol BD, Pradel E, Silva J, de La Canal LH, Becker M, Osório MF, Mansson M, Barreto R, Scheffer R (2017) Multiple resistance to acaricides in field populations of Rhipicephalus microplus from Rio Grande do Sul state, Southern Brazil. Ticks Tick Borne Dis 8: 73-80.
  29. Kumar P, Lata S, Shankar UN, Akif M (2021) Immunoinformatics based designing of a multi- epitope chimeric vaccine from multi-domain outer surface antigens of Leptospira. Front Immunol 12: 735373.
  30. Lew-Tabor AE, Valle MR (2016) A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases. Ticks Tick Borne Dis 7: 573-585.
  31. List C, Qi W, Maag E, Gottstein B, Müller N, Felger I (2010) Serodiagnosis of Echinococcus spp. infection: explorative selection of diagnostic antigens by peptide microarray. PLOS Negl Trop Dis 4: e771.
  32. Maiorano AM, Giglioti R, Oliveira MC, Oliveira HN, Cyrillo JN, Mercadante ME, Silva JA (2018) Resistance to the tick Rhipicephalus microplus and Babesia bovis infection levels in beef heifers raised in an endemic area of Sao Paulo state, Brazil Anim Prod Sci 59: 938-944.
  33. Mangold AJ, Vanzini VR, Echaide IE, De Echaide ST, Volpogni MM, Guglielmone AA (1996) Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro. Vet Parasitol 61: 345- 348.
  34. McElwain TF, Perryman LE, Musoke AJ, McGuire TC (1991) Molecular characterization and immunogenicity of neutralization-sensitive Babesia bigemina merozoite surface proteins. Mol Biochem Parasitol 47: 213-222.
  35. Mehla K, Ramana J (2016) Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichia coli: a comparative genomics and Immunoinformatics approach. Mol Biosyst 12: 890-901.
  36. Menezes-Souza D, Mendes TA, Nagem RA, Santos TT, Silva AL, Santoro MM, de Carvalho SF, Coelho EA, Bartholomeu DC, Fujiwara RT (2014) Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis. PloS One 9: e99216.
  37. Mercado-Uriostegui MA, Castro-Sánchez LA, Batiha GE, Valdez-Espinoza UM, Falcón-Neri A, Ramos-Aragon JA, Hernández-Ortiz R, Kawazu SI, Igarashi I, Mosqueda J (2022) The GP-45 Protein, a Highly Variable Antigen from Babesia bigemina, Contains Conserved B-Cell Epitopes in Geographically Distant Isolates. Pathogens 11: 591.
  38. Mishra VS, McElwain TF, Dame JB, Stephens EB (1992) Isolation, sequence and differential expression of the p58 gene family of Babesia bigemina. Mol Biochem Parasitol 53: 149-158.
  39. Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ (2012) Current advances in detection and treatment of babesiosis. Curr Med Chem 19: 1504-1518.
  40. Moubri K, Kleuskens J, Van de Crommert J, Scholtes N, Van Kasteren T, Delbecq S, Grenflot A, Schetters T (2018) Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection. Vet Parasitol 249: 21-29.
  41. Mucci J, Carmona SJ, Volcovich R, Altcheh J, Bracamonte E, Marco JD, Nielsen M, Buscaglia CA, Agüero F (2017) Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes. PLoS Negl Trop Dis 11: e0005972.
  42. Nabi H, Rashid I, Ahmad N, Durrani A, Akbar H, Islam S, Bajwa AA, Shehzad W, Ashraf K, Imran N (2017) Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii. Parasitol Res 116: 359-370.
  43. Naeem H, Sana M, Islam S, Khan M, Riaz F, Zafar Z, Akbar H, Shehzad W, Rashid MI (2018) Induction of Th1 type-oriented humoral response through intranasal immunization of mice with SAG1- Toxoplasma gondii polymeric nanospheres. Artif Cells Nanomed Biotechnol 46: 1025-1034.
  44. Patarroyo MF, Cifuentes G, Bermudez A, Patarroyo MA (2008) Strategies for developing multi‐epitope, subunit‐based, chemically synthesized anti‐malarial vaccines. J Cell Mol Med 12: 1915-1935.
  45. Rahman SU, Akbar H, Shabbir MZ, Ullah U, Rashid MI (2021) Development of Human Toxo IgG ELISA Kit, and False-Positivity of Latex Agglutination Test for the Diagnosis of Toxoplasmosis. Pathogens 10: 1111.
  46. Rashid I, Hedhli D, Moiré N, Pierre J, Debierre-Grockiego F, Dimier-Poisson I, Mévélec MN (2011) Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis. Vaccine 29: 8838-8846.
  47. Rauf U, Shabir S, Khan M, Rashid MI, Akbar H, Durrani AZ (2020) Identification of 23 kD immunogen from native antigens of Babesia bigemina in splenectomized calf. Int J Agric Biol 24: 1788-1794.
  48. Rauf U, Suleman M, Abid A, Jamil H, Menghwar H, Durrani AZ, Rashid MI, Akbar H (2020) Humoral and cell-mediated immune response validation in calves after a live attenuated vaccine of Babesia bigemina. Pathogens 9: 936.
  49. Rehman A, Conraths FJ, Sauter‐Louis C, Krücken J, Nijhof AM (2019) Epidemiology of tick‐ borne pathogens in the semi‐arid and the arid agro‐ecological zones of Punjab province, Pakistan. Transbound Emerg Dis 66: 526-536.
  50. Rodríguez-Camarillo SD, Quiroz-Castañeda RE, Aguilar-Díaz H, Vara-Pastrana JE, Pescador- Pérez D, Amaro-Estrada I, Martínez-Ocampo F (2020) Immunoinformatic analysis to identify proteins to be used as potential targets to control bovine anaplasmosis. Int J Microbiol 2020: 88.
  51. Islam MS, Aryasomayajula A, Selvaganapathy PR (2017) A review on macroscale and microscale cell lysis methods. Micromachines 8: 83
  52. Shkap V, Leibovitz B, Krigel Y, Hammerschlag J, Marcovics A, Fish L, Molad T, Savitsky I, Mazuz M (2005) Vaccination of older Bos taurus bulls against bovine babesiosis. Vet Parasitol 129: 235-242.
  53. Siddique RM, Sajid MS, Iqbal Z, Saqib M (2020) Association of different risk factors with the prevalence of babesiosis in cattle and buffalos. Pak J Agri Sci 57: 517-524.
  54. Silva MG, Knowles DP, Suarez CE (2016) Identification of interchangeable cross-species function of elongation factor-1 alpha promoters in Babesia bigemina and Babesia bovis. Parasit Vectors 9: 576.
  55. Singh H, Mishra AK, Rao JR, Tewari AK (2009) Comparison of indirect fluorescent antibody test (IFAT) and slide enzyme linked immunosorbent assay (SELISA) for diagnosis of Babesia bigemina infection in bovines. Trop Anim Health Prod 41: 153- 159.
  56. Teimouri A, Modarressi MH, Shojaee S, Mohebali M, Rezaian M, Keshavarz H (2019) Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections. Infect Drug Resist 12: 2657-2669.
  57. Tuvshintulga B, Sivakumar T, Yokoyama N, Igarashi I (2019) Development of unstable resistance to diminazene aceturate in Babesia bovis. Int J Parasitol: Drugs Drug Resist 9: 87-92.
  58. Uilenberg G (2006) Babesia—a historical overview. Vet Parasitol 138: 3-10.
  59. Wagner GG, Holman P, Waghela S (2002) Babesiosis and heart water: threats without boundaries. Vet Clin North Am Food Anim Pract 18: 417-430.
  60. Wieser SN, Schnittger L, Florin-Christensen M, Delbecq S, Schetters T (2019) Vaccination against babesiosis using recombinant GPI-anchored proteins. Int J Parasitol 49: 175-181.
  61. Wright IG, Goodger BV, Leatch G, Aylward JH, Rode-Bramanis K, Waltisbuhl DJ (1987) Protection of Babesia bigemina-immune animals against subsequent challenge with virulent Babesia bovis. Infect Immun 55: 364-368.
  62. Yadav S, Prakash J, Shukla H, Das KC, Tripathi T, Dubey VK (2020) Design of a multi- epitope subunit vaccine for immune-protection against Leishmania parasite. Pathog Glob Health 114: 471-481.
  63. Yoshida M, Reyes SG, Tsuda S, Horinouchi T, Furusawa C, Cronin L (2017) Time- programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro. Nat Commun 8: 15589.
Go to article

Authors and Affiliations

Z. Ul Rehman
1
M. Suleman
2
K. Ashraf
1
S Ali
1
S. Rahman
1
M.I. Rashid
1

  1. Department of Parasitology, University of Veterinary and Animal Sciences, Syed Abdul Qadir Jillani (Out Fall) Road, Lahore, 54000, Pakistan
  2. University Diagnostic Laboratory, Institute of Microbiology, University of Veterinary and Animal Sciences, Syed Abdul Qadir Jillani (Out Fall) Road, Lahore, 54000, Pakistan
Download PDF Download RIS Download Bibtex

Abstract

Azo dye is widely used in the textile industry since it is cost effective and simple to use. However, it becomes a continuous source of environmental pollution due to its carcinogenicity and toxicity. Various methods had been used to remove the azo dye in solution. One of the famous and frequently used is the Fenton process. The Fenton process is one of the advanced oxidation processes where iron catalysed hydrogen peroxide to generate hydroxyl radical. Treating azo dyes in solution requires a catalyst to enhance the process of degradation. Herein, high entropy alloys (HEAs) have been proposed as a catalytic material to enhance the performance of Fenton process for azo dye degradation. HEAs have been reported as a promising catalyst due to its high surface area. The higher the number of active sites, the higher the rate of azo dye degradation as more active sites are available for adsorption of azo dyes. The results have shown that HEAs can be used as a catalyst to fasten the Fenton reaction since the degradation time is proven to be shorter in the presence of HEAs. The method derived from the result of this study will contribute in treating azo dyes for wastewater management in the Fenton process.
Go to article

Authors and Affiliations

N.H.A. Hassan
1
ORCID: ORCID
N.S.M. Nasir
1
ORCID: ORCID
S.N.A. Rahman
1
ORCID: ORCID
A.R. Irfan
2 3
ORCID: ORCID
N.H. Nordin
1
ORCID: ORCID

  1. International Islamic University Malaysia, Department of Manufacturing and Materials Engineering, Jalan Gombak, 53100 Kuala Lumpur, Malaysia
  2. Universiti Malaysia Perlis, Faculty of Mechanical Engineering Technology, Perlis, Malaysia
  3. Universiti Malaysia Perlis, Center of Excellence Geopolymer and Green Technology (CEGeoGTech), Perlis, Malaysia

This page uses 'cookies'. Learn more